Nuveen
AORT icon

Nuveen’s Artivion AORT Stock Holding History

Nuveen’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
108,893
+21,886
+25% +$612K ﹤0.01% 2472
2026
Q1 		$3.19M Sell
87,007
-82,834
-49% -$3.27M ﹤0.01% 2085
2025
Q4 		$7.75M Buy
169,841
+87,403
+106% +$3.89M ﹤0.01% 1708
2025
Q3 		$3.49M Sell
82,438
-2,424
-3% -$91.4K ﹤0.01% 2082
2025
Q2 		$2.64M Sell
84,862
-23,064
-21% -$624K ﹤0.01% 2175
2025
Q1 		$2.65M Buy
107,926
+286
+0.3% +$7.94K ﹤0.01% 2216
2024
Q4 		$3.08M Sell
107,640
-8,877
-8% -$246K ﹤0.01% 2205
2024
Q3 		$3.1M Hold
116,517
– – ﹤0.01% 2217
2024
Q2 		$2.99M Sell
116,517
-68,180
-37% -$1.53M ﹤0.01% 2188
2024
Q1 		$3.91M Sell
184,697
-74,057
-29% -$1.38M ﹤0.01% 2108
2023
Q4 		$4.63M Buy
258,754
+14,574
+6% +$227K ﹤0.01% 2029
2023
Q3 		$3.7M Sell
244,180
-179
-0.1% -$2.9K ﹤0.01% 2015
2023
Q2 		$4.2M Buy
244,359
+17,744
+8% +$261K ﹤0.01% 2009
2023
Q1 		$2.97M Sell
226,615
-12,407
-5% -$159K ﹤0.01% 2172
2022
Q4 		$2.9M Buy
239,022
+115,462
+93% +$1.39M ﹤0.01% 2214
2022
Q3 		$1.71M Sell
123,560
-2,151
-2% -$43.3K ﹤0.01% 2479
2022
Q2 		$2.37M Buy
125,711
+2,028
+2% +$39.1K ﹤0.01% 2342
2022
Q1 		$2.58M Sell
123,683
-24,288
-16% -$469K ﹤0.01% 2386
2021
Q4 		$3.01M Sell
147,971
-7,990
-5% -$161K ﹤0.01% 2367
2021
Q3 		$3.48M Buy
155,961
+20,586
+15% +$530K ﹤0.01% 2411
2021
Q2 		$3.85M Sell
135,375
-9,757
-7% -$266K ﹤0.01% 2377
2021
Q1 		$3.28M Sell
145,132
-66,635
-31% -$1.63M ﹤0.01% 2375
2020
Q4 		$5M Buy
211,767
+61,112
+41% +$1.24M ﹤0.01% 2078
2020
Q3 		$2.78M Buy
150,655
+11,175
+8% +$214K ﹤0.01% 2217
2020
Q2 		$2.67M Sell
139,480
-873
-0.6% -$18.5K ﹤0.01% 2217
2020
Q1 		$2.38M Buy
140,353
+4,023
+3% +$103K ﹤0.01% 2107
2019
Q4 		$3.69M Sell
136,330
-41,609
-23% -$1.02M ﹤0.01% 2144
2019
Q3 		$4.83M Buy
177,939
+2,255
+1% +$63.9K ﹤0.01% 1973
2019
Q2 		$5.26M Buy
+175,684
New +$5.21M ﹤0.01% 1958

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Nuveen's AORT Position: Q2 2026 in Review

Nuveen increased its Artivion (AORT) stake by 25% in Q2 2026, buying an estimated $612K and bringing the position to 108,893 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Nuveen first reported a position in AORT in Q2 2019 and has held it in 29 quarters since. The position peaked at $7.75M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Nuveen held 108,893 shares of Artivion worth $2.45M as of Q2 2026.
  • Nuveen bought 21,886 Artivion shares in Q2 2026, an estimated $612K.
  • Artivion made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2472 holding.
  • Nuveen first reported a position in Artivion in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Artivion position peaked at $7.75M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.